Clinical trials
Phase 2/3 Thrombocythemia, Essential trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| French Innovative Leukemia Organisation | 1 |
| Roswell Park Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 2 |
| Anemia, Aplastic | 1 |
| Anemia, Refractory | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blast Crisis | 1 |
| Burkitt Lymphoma | 1 |
| Congenital Abnormalities | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Immunoblastic Lymphadenopathy | 1 |
| Intraocular Lymphoma | 1 |
Trials
Showing 76 to 2 of 2. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.